Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma

Aarati Ranganathan, Alex Adjei, Primo Lara

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)170-178
Number of pages9
JournalClinical lung cancer
Issue number3
StatePublished - Nov 2006

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this